Related by context. Frequent words. (Click for all words.) 73 Meets Primary Endpoint 73 Initiate Phase 72 Completes Patient Enrollment 72 VEGFR2 inhibitor 72 Pivotal Phase 71 Belimumab 71 rheumatoid arthritis psoriatic arthritis 71 refractory chronic lymphocytic 71 R sorafenib tablets 71 interferon gamma 1b 71 Acetate Rectal Suppositories 70 Lubiprostone 70 Pivotal Phase III 70 St. Downers Grove 70 Panzem R 70 MKC# 70 EARNINGS LOOK AHEAD 69 Am J Obstet 69 g trans fats 69 Study Evaluating 69 YOUR LOCAL ANIMAL SHELTER 69 CIMZIA TM 69 Receives Orphan Drug Designation 69 Initiates Phase II 69 Coadministration 69 GVAX R 68 Phase Ib IIa 68 See BioWorld Today 68 Chronic Hepatitis C 68 plus methotrexate 68 Clevudine 68 2 methoxyestradiol 68 neutropenia thrombocytopenia 68 TAXUS p value 68 HMG CoA reductase inhibitors 68 Prulifloxacin 67 Natalizumab 67 recurrent glioblastoma multiforme 67 plus prednisone 67 doxazosin 67 RhuDex ® 67 Noncritical violations found 67 desvenlafaxine succinate 67 ® bortezomib 67 Initiates Phase 67 Rebif ® 67 Sodium oxybate 67 J Allergy Clin 67 Single Dose 67 Completes Enrollment 67 Clinical Trials Update 67 J Am Acad 67 Cutaneous T 67 J Am Coll 67 includes investigational compounds 67 Daclizumab 67 active ankylosing spondylitis 67 ORENCIA R 67 forodesine 67 CHEAP ONLINE PHARMACY LOW 66 mg TID 66 Ann Oncol 66 Presents Positive 66 plus dexamethasone 66 diabetic peripheral neuropathic DPN 66 liposomal formulation 66 gets USFDA nod 66 teriflunomide 66 Denufosol 66 multi kinase inhibitor 66 signal detection CTSD 66 Kepivance 66 Marcus Gronholm BP 66 fibrosis IPF 66 6R BH4 66 Vandetanib 66 receiving VELCADE 66 Epratuzumab 66 Suppl. 66 mg QD 66 hypophosphatemia 66 Previously Treated 66 cutaneous T 66 HGS ETR2 66 Commences Phase 66 SOCIAL IN BRIEF 66 Golimumab 66 Kinase Inhibitor 66 plus OBT 66 Ixempra 66 lopinavir r arm 66 Cream USP 1 66 plus gemcitabine 66 Inhalation Aerosol 66 Sapacitabine 66 Plicera 66 DDP# 65 Eltrombopag 65 Staccato prochlorperazine 65 metastatic hormone refractory 65 pegylated interferon alfa 2a